Publication | Open Access
Perampanel as precision therapy in rare genetic epilepsies
38
Citations
15
References
2023
Year
Perampanel demonstrated high safety and efficacy in patients with rare genetic epilepsies, especially in SCN1A, GNAO1, PIGA, PCDH19, SYNGAP1, CDKL5, NEU1, and POLG, suggesting a targeted effect related to glutamate transmission.
| Year | Citations | |
|---|---|---|
Page 1
Page 1